SG3 Management, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,961,800
+1070.7%
80,000
+501.5%
0.20%
+570.0%
Q2 2022$253,000
-87.7%
13,300
-82.5%
0.03%
-48.3%
Q1 2022$2,051,000
+415.3%
76,000
+572.6%
0.06%
+480.0%
Q1 2021$398,00011,3000.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders